Wednesday May 22, 2019

Know Which Medication Can Help By Protecting You From Familial Breast Cancer

Earlier Austrian studies have given strong indications that Denosumab may be effective against breast cancer, experts said

0
//
woman
Up to now the only preventative measure against both cancers has been surgical removal of the affected breast tissue or the ovaries. Pixabay

Breast cancer passed down in families may be preventable by the medication Denosumab, which is undergoing a five-year study in Austria.

The Austrian Breast and Colorectal Cancer Study Group is leading the work as it examines the drug’s effectiveness on 2,950 patients with a hereditary disposition to this particular form of cancer, according to an Austria Press Agency report.

Speaking at a press conference on Thursday, Professor Christian Singer from the Vienna General Hospital said the study will also examine the effects of Denosumab on healthy women who have a mutation in the BRCA1 gene, reports Xinhua news agency.

gene
enosumab is known as a monoclonal antibody and has been used in particular to treat osteoporosis, due to its capacity to prevent the development of cells that break down bone. Pixabay

These women have a 1.8 per cent chance of developing breast cancer each year, or about an 80 per cent chance during their lifetime. In addition, they have a 50 per cent chance of developing ovarian cancer.

Up to now the only preventative measure against both cancers has been surgical removal of the affected breast tissue or the ovaries.

test
The Austrian Breast and Colorectal Cancer Study Group is leading the work as it examines the drug’s effectiveness on 2,950 patients with a hereditary disposition to this particular form of cancer, according to an Austria Press Agency report. Pixabay

The participants in the drug trial will receive either a Denosumab injection or a placebo every six months, Singer said.

Also Read: Intel Stock Fell as Chip Maker cut Revenue Forecast

Denosumab is known as a monoclonal antibody and has been used in particular to treat osteoporosis, due to its capacity to prevent the development of cells that break down bone.

Earlier Austrian studies have given strong indications that Denosumab may be effective against breast cancer, experts said. (IANS)

Next Story

Women with Sleep Apnea at Greater Cancer Risk, Warn Researchers

The data showed that 2.8 per cent of all women had been diagnosed with a serious cancer compared to 1.7 per cent of all men in the group

0
Previous research has shown that obesity and high-fat diets both together and independently increase the risk of pancreatic cancer.
The actress was diagnosed with cancer earlier this year. Pixabay

Women with obstructive sleep apnea (OSA) are more likely to be diagnosed with cancer than men with the condition, warn researchers.

Common symptoms of sleep apnea, include snoring, disrupted sleep and fatigue.

“Our study of more than 19,000 people shows that the severity of OSA is linked to a cancer diagnosis,” said study lead author Athanasia Pataka, Assistant Professor at Aristotle University of Thessaloniki in Greece.

“This link was especially strong in the women that we analysed, and less so in the men, and the study suggests that severe OSA could be an indicator for cancer in women, though more research is needed to confirm these findings,” Pataka explained.

In people suffering from OSA, the airways close completely or partially many times during sleep, reducing the levels of oxygen in the blood.

Cancer patient
Cancer patient.

The researchers analysed data from 19,556 people (5,789 women and 13,767 men) included in the European Sleep Apnoea Database (ESADA) to explore the link between OSA severity, low blood oxygen levels and cancer development.

The researchers looked at the number of times the participants experienced partial or complete airways closure per hour of sleep, as well as the number of times their blood oxygen levels dropped below 90 per cent at night.

Also Read- Sepsis Subtypes Identified, Different Remedies Stressed

The data showed that 2.8 per cent of all women had been diagnosed with a serious cancer compared to 1.7 per cent of all men in the group.

The study, published in the European Respiratory Journal, suggests that people who experience more closures of the airways during sleep and whose blood oxygen saturation levels drop below 90 per cent more frequently are more likely to be diagnosed with cancer than people without OSA. (IANS)